: Agile Therapeutics stock price target cut to $4 from $6 at Maxim

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Agile Therapeutics Inc.

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

1 BUSINESS

Business News - Opportunities - Reviews

 

 

Leave a Reply